Epidemic retinitis during the COVID-19 pandemic

Simple item page
dc.contributor.authorKawali, Ankushen_US
dc.contributor.authorSrinivasan, Sanjayen_US
dc.contributor.authorMishra, Sai Bhaktien_US
dc.contributor.authorMahendradas, Padmamalinien_US
dc.contributor.authorShetty, Bhujangen_US
dc.date.accessioned2023-08-25T06:37:42Z
dc.date.available2023-08-25T06:37:42Z
dc.date.issued2023-07
dc.description.abstractPurpose: To study the impact of the novel coronavirus disease?2019 (COVID?19) pandemic on incidence, seasonal variation, clinical presentation, and disease outcome of epidemic retinitis (ER) and to compare clinical outcomes with positive and negative COVID?19 serology. Methods: This is a retrospective, observational study conducted at a tertiary eye care hospital from August 2020 to June 2022. A graph of ER cases against the month of presentation was compared with the graph of the COVID?19 pandemic in the same region. Cases presented before COVID?19 vaccination, with positive COVID?19 serology (Group 1) were compared with cases with negative serology (Group 2). Results: One hundred and thirty?two cases of ER were seen. The least number of cases were seen during and immediately after the peak of the pandemic (May 2021–August 2021). COVID?19 serology was positive in 13 (22 eyes)/60 (21.6%) unvaccinated cases. Along with COVID?19, positive serology for other ER etiologies was seen in 5/13 cases (38.4%). All patients received oral doxycycline with/without steroids. Groups 1 and 2 included 22 and 21 eyes of 13 cases each. Macular edema resolved in 43.6 and 32 days in groups 1 and 2, respectively. Retinitis resolved at 1 month in both groups. Corrected distant visual acuity was 20/50 and 20/70 at the presentation, which improved to 20/20 and 20/25 in groups 1 and 2, respectively. Mean and median follow?up was 6 months and 4.5 months, respectively, in both groups. No complications or recurrences were seen. Conclusion: No significant impact of the COVID?19 pandemic on ER was observeden_US
dc.identifier.affiliationsDepartment of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, Karnataka, Indiaen_US
dc.identifier.affiliationsDepartment of General Ophthalmology, Narayana Nethralaya, Bangalore, Karnataka, Indiaen_US
dc.identifier.citationKawali Ankush, Srinivasan Sanjay, Mishra Sai Bhakti, Mahendradas Padmamalini, Shetty Bhujang. Epidemic retinitis during the COVID-19 pandemic. Indian Journal of Ophthalmology. 2023 Jul; 71(7): 2779-2783en_US
dc.identifier.issn1998-3689
dc.identifier.issn0301-4738
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/225128
dc.languageenen_US
dc.publisherAll India Ophthalmological Societyen_US
dc.relation.issuenumber7en_US
dc.relation.volume71en_US
dc.source.urihttps://doi.org/10.4103/IJO.IJO_3349_22en_US
dc.subjectCoronavirusen_US
dc.subjectCOVIDen_US
dc.subjectepidemic retinitisen_US
dc.subjectmultifocal retinitisen_US
dc.subjectneuroretinitisen_US
dc.subjectpandemicen_US
dc.subjectpost?fever retinitisen_US
dc.subjectseasonal variationen_US
dc.subjectseropositiveen_US
dc.titleEpidemic retinitis during the COVID-19 pandemicen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IJO2023v71n7p2779.pdf
Size:
1.52 MB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Ophthalmology